Skip to main content
OpenTrials
Completed

NCT Number: NCT06382727

CONTINUation of Enteral Nutrition Prior to Extubation Compared to Standard Care

Critically ill patients admitted to the Intensive Care Unit (ICU) often need to be connected to a breathing machine (ventilator) and are unable to eat. During this time, liquid nutrition is delivered via a feeding tube to the stomach or bowel (termed enteral nutrition (EN)) to ensure nutrition needs are provided until such time that the patient can eat normally.

The delivery of nutrition via EN is frequently interrupted due to procedures and changes in the gastrointestinal system that can cause digestion to be slow. One of the main contributors to EN interruptions is fasting prior to removal of the breathing tube (termed extubation).

The practice of pausing EN prior to the removal of the breathing tube is historical and based on evidence for patients who are not within the ICU. There is currently no scientific consensus on whether pausing of EN is necessary, or for how long. Because of this, some clinicians choose to pause EN prior to removal of the breathing tube and some clinicians continue to provide EN.

This study is a pilot randomised controlled trial of fasting patients for at least 4 hours prior to removal of the breathing tube compared with not pausing EN. The investigators hypothesise that this will reduce the number of hours of fasting in the 24 hours prior to extubation.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Gold Coast University Hospital, Southport, Queensland, Australia

Loading trial locations.

About this study

The provision of EN is standard practice to mechanically ventilated patients within the ICU. Delivery is frequently interrupted, with patients often receiving approximately half of prescribed volumes. One of the main contributors to this is fasting prior to extubation. Fasting prior to extubation is historically informed from pre-anaesthetic practice in patients who are not critically ill where fasting allows for adequate gastric emptying and reduces the risk of aspiration on induction. The practice of fasting prior to extubation is less informed, and variable. A recent scoping review identified only 1 randomised controlled trial (RCT) and 13 observational studies on this topic. The review found fasting durations varied between 0-34 hours and the reasons for fasting prior to extubation were safety related; however, these reasons were often extrapolated from data outside of the ICU as outlined above. The review concluded that there is an evidence gap and no evidence-based consensus as to the rationale and duration of fasting critically ill patients prior to extubation.

The clinical consequences of fasting (and particularly repeated fasting) are not well understood; however, it is known that fasting leads to reduced nutrition which may negatively impact response to illness, particularly in patients with a long length of stay. Beyond this, the requirement for fasting may delay extubation and progression of care (as extubation may be cancelled if the patient is not adequately fasted) and lead to unnecessary use for nursing and medical resources.

The CONTINUE trial represents the first trial of its kind in Australia and seeks to determine feasibility to inform a program of research that addresses a universal practice for critically ill patients requiring mechanical ventilation. Establishment of feasibility will provide data to inform a large RCT of similar nature, powered to determine differences in important clinical outcomes such as reintubation rate, ventilator free days to day 28 of admission and development of aspiration pneumonia. The culmination of this research will be to create an evidence-based guideline on pre-extubation fasting with the aim of standardising and informing international practice.

The primary aim is to determine whether continuing EN to the point of extubation and performing maximal nasogastric aspiration immediately prior is feasible and decreases total fasting in the time 24 hours prior to extubation compared to standard practice of ceasing EN 4- 6 hours prior to planned extubation, in low risk ventilated patients. Secondary objectives include assessment of important safety related endpoints including change in oxygenation requirements, aspiration, reintubation rate at 48 hours after extubation and clinical outcome measures including ICU and hospital morbidity and mortality.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • 18 years or older
  • Receiving invasive mechanical ventilation > 24 hours and < 10 days in the index ICU admission
  • Receiving EN at a rate ≥ 30ml/hr
  • Planned for extubation within the hours of 0800-1800

Exclusion criteria

  • EN delivery via a fine bore nasogastric tube that is unable to be aspirated
  • A single gastric residual volume ≥ the maximum protocol limit at the participating site has been recorded within the last 24 hours
  • Currently receiving extracorporeal membrane oxygenation
  • Acute neurological pathology
  • A time critical medication is required via the enteral route (including anti-parkinsons and immunosuppressant medication) and no adjustments can be made
  • Pre-existing swallow, bulbar dysfunction and/or concern around inadequate airway protection
  • A laparotomy has been performed within 72 hours of planned extubation
  • Confirmed pregnancy
  • Patient not deemed appropriate to be reintubated in the event of deterioration
  • Treating clinician believes enrolment is not in the best interests of the patient

Treatment and study plan

EN will be continued up to extubation (EN will not be withheld prior to extubation)

Other

As per the arm/group descriptions.

Primary outcomes

  1. Fasting time (hours)

    Time frame: 24 hours prior to endotracheal tube removal

    Fasting time due to planned extubation

Secondary outcomes

  1. Reintubation rate

    Time frame: 48 hours post endotracheal tube removal

    Actual reintubation rate and according to an objective criterion for failure:

    Respiratory acidosis (pH <7.35 with Paco2 >45 mm Hg); Spo2 less than 90% or Pao2 less than 60 mm Hg at Fio2 greater than 0.4; Respiratory rate greater than 35/min; Decreased level of consciousness (defined as a decrease in GCS score >1 point); Agitation, or clinical signs suggestive of respiratory muscle fatigue, increased work of breathing (eg, the use of respiratory accessory muscles, paradoxical abdominal motion, or retraction of the intercostal spaces), or both; Patients dying within 72 hours will also be considered as extubation failures.

  2. Days alive and free of mechanical ventilation

    Time frame: Up to day 28 post randomisation

    Number of days alive and free of mechanical ventilation

  3. Commencement of antibiotics

    Time frame: Up to 7 days post endotracheal tube removal

    Commencement of antibiotics for a chest infection or aspiration

  4. Ratio of oxygen saturation (SpO2)/ fraction of inspired oxygen (FiO2)

    Time frame: 12 hours post endotracheal tube removal

    SpO2:FiO2 ratio

  5. ICU length of stay

    Time frame: Up to day 28 post randomisation

    ICU length of stay (days)

  6. In-hospital mortality

    Time frame: Up to day 28 post randomisation

    In-hospital mortality during ICU or acute ward admission

  7. Nutrition delivery

    Time frame: 24 hours prior to endotracheal tube removal

    The absolute and relative (to calculated requirements) amount of calories delivered

  8. Recruitment rate

    Time frame: Up to the end of the study period

    Number of patients recruited per month

  9. Protocol compliance

    Time frame: Up to Endotracheal Tube removal

    Defined as the proportion of patients receiving the allocated intervention

Sponsors and collaborators

Lead sponsor

Emma Ridley

Other

Registry information

Official study title

CONTINUation of Enteral Nutrition Prior to Extubation Compared to Standard Care: A Pilot Randomised Controlled Trial (CONTINUE Trial)

Acronym: CONTINUE

Important dates

Study start
2024
Primary completion
2025
Study completion
2025
First posted
Apr 24, 2024
Registry last updated
May 8, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.